Development of novel monoclonal antibodies that define differentiation stages of human stromal (mesenchymal) stem cells

[1]  J. Salomonsen,et al.  Two mannose-binding lectin homologues and an MBL-associated serine protease are expressed in the gut epithelia of the urochordate species Ciona intestinalis. , 2010, Developmental and comparative immunology.

[2]  A. Zannettino,et al.  Molecular cloning of the cell surface antigen identified by the osteoprogenitor‐specific monoclonal antibody, HOP‐26 , 2003, Journal of cellular biochemistry.

[3]  D. Benayahu,et al.  Single‐Colony Derived Strains of Human Marrow Stromal Fibroblasts Form Bone After Transplantation In Vivo , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[4]  A. Zannettino,et al.  A novel monoclonal antibody (STRO-3) identifies an isoform of tissue nonspecific alkaline phosphatase expressed by multipotent bone marrow stromal stem cells. , 2007, Stem cells and development.

[5]  N. Fernández,et al.  Human major histocompatibility molecules have the intrinsic ability to form homotypic associations. , 1999, Human immunology.

[6]  R. Cancedda,et al.  Expression of the cartilage matrix protein gene at different chondrocyte developmental stages. , 1995, European journal of cell biology.

[7]  C. Milstein,et al.  Continuous cultures of fused cells secreting antibody of predefined specificity , 1975, Nature.

[8]  P. Herrlich,et al.  The two major CD44 proteins expressed on a metastatic rat tumor cell line are derived from different splice variants: each one individually suffices to confer metastatic behavior. , 1993, Cancer research.

[9]  S. Gronthos,et al.  Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow , 2003, Journal of Cell Science.

[10]  J. Zaia,et al.  The monoclonal antibody SH-2, raised against human mesenchymal stem cells, recognizes an epitope on endoglin (CD105). , 1999, Biochemical and biophysical research communications.

[11]  P. Bonaldo,et al.  Multiple forms of chicken alpha 3(VI) collagen chain generated by alternative splicing in type A repeated domains , 1990, The Journal of cell biology.

[12]  M. Kassem,et al.  Human mesenchymal stem cells: from basic biology to clinical applications , 2008, Gene Therapy.

[13]  C. Ryu,et al.  Development of a decoy immunization strategy to identify cell-surface molecules expressed on undifferentiated human embryonic stem cells , 2008, Cell and Tissue Research.

[14]  C. Reading,et al.  Theory and methods for immunization in culture and monoclonal antibody production. , 1982, Journal of immunological methods.

[15]  M. Kassem,et al.  Identifying a molecular phenotype for bone marrow stromal cells with in vivo bone‐forming capacity , 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[16]  P. Conget,et al.  Mesenchymal Stem Cells , 2001, Experimental biology and medicine.

[17]  Blagoy Blagoev,et al.  Mechanism of Divergent Growth Factor Effects in Mesenchymal Stem Cell Differentiation , 2005, Science.

[18]  L. Mosekilde,et al.  Formation of osteoclasts and osteoblast‐like cells in long‐term human bone marrow cultures , 1991, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[19]  M. Mann,et al.  Differential Expression Profiling of Membrane Proteins by Quantitative Proteomics in a Human Mesenchymal Stem Cell Line Undergoing Osteoblast Differentiation , 2005, Stem cells.

[20]  S. Gronthos,et al.  The STRO-1+ fraction of adult human bone marrow contains the osteogenic precursors. , 1994, Blood.

[21]  P. Bollen,et al.  Characterization of DLK1+ Cells Emerging During Skeletal Muscle Remodeling in Response to Myositis, Myopathies, and Acute Injury , 2009, Stem cells.

[22]  J. Ringe,et al.  Specific plasma membrane protein phenotype of culture-amplified and native human bone marrow mesenchymal stem cells. , 2008, Blood.

[23]  S. Perez,et al.  Characterization of the Optimal Culture Conditions for Clinical Scale Production of Human Mesenchymal Stem Cells , 2006, Stem cells.

[24]  Ramalho-Santos.  Chondrogenic Differentiation of Human Pluripotent Cells , 2009 .

[25]  K. Mrozik,et al.  Heat shock protein-90 beta is expressed at the surface of multipotential mesenchymal precursor cells: generation of a novel monoclonal antibody, STRO-4, with specificity for mesenchymal precursor cells from human and ovine tissues. , 2009, Stem cells and development.

[26]  J. Lotz,et al.  Chondrogenic differentiation of human mesenchymal stem cells in three-dimensional alginate gels. , 2008, Tissue engineering. Part A.

[27]  J. Zaia,et al.  The SH-3 and SH-4 antibodies recognize distinct epitopes on CD73 from human mesenchymal stem cells. , 2001, Biochemical and biophysical research communications.

[28]  Y. Lau,et al.  MHC expression kinetics and immunogenicity of mesenchymal stromal cells after short-term IFN-gamma challenge. , 2008, Experimental hematology.

[29]  H. Folkesson,et al.  Type VI collagen induces cardiac myofibroblast differentiation: implications for postinfarction remodeling. , 2006, American journal of physiology. Heart and circulatory physiology.

[30]  P. Simmons,et al.  Identification of stromal cell precursors in human bone marrow by a novel monoclonal antibody, STRO-1. , 1991, Blood.

[31]  S. Bruder,et al.  Monoclonal antibodies reactive with human osteogenic cell surface antigens. , 1997, Bone.

[32]  M. Kassem,et al.  Maintenance of differentiation potential of human bone marrow mesenchymal stem cells immortalized by human telomerase reverse transcriptase gene despite [corrected] extensive proliferation. , 2005, Biochemical and biophysical research communications.

[33]  Bruno Delorme,et al.  Human bone marrow native mesenchymal stem cells. , 2008, Regenerative medicine.

[34]  Mara Riminucci,et al.  Bone Marrow Stromal Stem Cells: Nature, Biology, and Potential Applications , 2001, Stem cells.

[35]  F. Liu,et al.  Changes in the expression of CD106, osteogenic genes, and transcription factors involved in the osteogenic differentiation of human bone marrow mesenchymal stem cells , 2008, Journal of Bone and Mineral Metabolism.

[36]  J. Triffitt,et al.  Identification and enrichment of human osteoprogenitor cells by using differentiation stage-specific monoclonal antibodies. , 1997, Bone.

[37]  A. Caplan,et al.  Cell surface antigens on human marrow-derived mesenchymal cells are detected by monoclonal antibodies. , 1992, Bone.

[38]  T. Jensen,et al.  Telomerase expression extends the proliferative life-span and maintains the osteogenic potential of human bone marrow stromal cells , 2002, Nature Biotechnology.